EPZM - Epizyme GAAP EPS of -$0.38 misses by $0.03 revenue of $8.69M misses by $1.33M
Epizyme press release (NASDAQ:EPZM): Q1 GAAP EPS of -$0.38 misses by $0.03. Revenue of $8.69M (+13.9% Y/Y) misses by $1.33M. Cash, cash equivalents and marketable securities were $199.7 million as of March 31, 2022, compared to $176.8 million as of December 31, 2021.
For further details see:
Epizyme GAAP EPS of -$0.38 misses by $0.03, revenue of $8.69M misses by $1.33M